Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127071061 | 12707106 | 1 | I | 20150706 | 20150718 | 20160901 | 20160901 | EXP | US-PFIZER INC-2015241926 | PFIZER | 60.00 | YR | M | Y | 94.00000 | KG | 20160901 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127071061 | 12707106 | 1 | PS | IBUPROFEN. | IBUPROFEN | 1 | Oral | UNK | Y | 18989 | TABLET | ||||||||
| 127071061 | 12707106 | 2 | SS | IBUPROFEN. | IBUPROFEN | 1 | Y | 18989 | TABLET | ||||||||||
| 127071061 | 12707106 | 3 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, QD | 0 | 40 | MG | QD | |||||||
| 127071061 | 12707106 | 4 | C | POTASSIUM | POTASSIUM | 1 | Oral | 1 TAB, QD | 0 | 1 | DF | TABLET | QD | ||||||
| 127071061 | 12707106 | 5 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Oral | 1 TAB, PRN | 0 | 1 | DF | TABLET | |||||||
| 127071061 | 12707106 | 6 | C | CALCIUM | CALCIUM | 1 | Oral | 1 TAB, QD | 0 | 1 | DF | TABLET | QD | ||||||
| 127071061 | 12707106 | 7 | C | DEPO-MEDROL | METHYLPREDNISOLONE ACETATE | 1 | 40 MG, PRN | 0 | 40 | MG | INJECTION | ||||||||
| 127071061 | 12707106 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 127071061 | 12707106 | 9 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 25 MG, BID | 0 | 25 | MG | BID | |||||||
| 127071061 | 12707106 | 10 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | 0.5 MG, PRN | 0 | .5 | MG | ||||||||
| 127071061 | 12707106 | 11 | C | FINASTERIDE. | FINASTERIDE | 1 | Oral | 5 MG, QD | 0 | 5 | MG | QD | |||||||
| 127071061 | 12707106 | 12 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 325 MG, QD | 0 | 325 | MG | QD | |||||||
| 127071061 | 12707106 | 13 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 50 MG, BID | 0 | 50 | MG | BID | |||||||
| 127071061 | 12707106 | 14 | C | RANEXA | RANOLAZINE | 1 | Oral | 500 MG, QD | 0 | 500 | MG | QD | |||||||
| 127071061 | 12707106 | 15 | C | ALFUZOSIN | ALFUZOSIN | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 127071061 | 12707106 | 16 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 127071061 | 12707106 | 17 | C | STOOL SOFTENER | DOCUSATE CALCIUM | 1 | Oral | 100 MG, PRN | 0 | 100 | MG | ||||||||
| 127071061 | 12707106 | 18 | C | XANAX | ALPRAZOLAM | 1 | Oral | 0.5 MG, PRN | 0 | .5 | MG | ||||||||
| 127071061 | 12707106 | 19 | C | FISH OIL | FISH OIL | 1 | Oral | 1 TAB, QD | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127071061 | 12707106 | 1 | Osteoarthritis |
| 127071061 | 12707106 | 2 | Rheumatoid arthritis |
| 127071061 | 12707106 | 3 | Prophylaxis |
| 127071061 | 12707106 | 4 | Supplementation therapy |
| 127071061 | 12707106 | 5 | Osteoarthritis |
| 127071061 | 12707106 | 6 | Supplementation therapy |
| 127071061 | 12707106 | 7 | Arthralgia |
| 127071061 | 12707106 | 8 | Hypertension |
| 127071061 | 12707106 | 9 | Hypertension |
| 127071061 | 12707106 | 10 | Anxiety |
| 127071061 | 12707106 | 11 | Prostatomegaly |
| 127071061 | 12707106 | 12 | Cardiovascular event prophylaxis |
| 127071061 | 12707106 | 13 | Hypertension |
| 127071061 | 12707106 | 14 | Angina pectoris |
| 127071061 | 12707106 | 15 | Prostatomegaly |
| 127071061 | 12707106 | 16 | Blood cholesterol increased |
| 127071061 | 12707106 | 17 | Constipation |
| 127071061 | 12707106 | 18 | Anxiety |
| 127071061 | 12707106 | 19 | Supplementation therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127071061 | 12707106 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127071061 | 12707106 | Chest pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127071061 | 12707106 | 1 | 20140628 | 20160106 | 0 | |
| 127071061 | 12707106 | 3 | 20140627 | 0 | ||
| 127071061 | 12707106 | 4 | 2011 | 0 | ||
| 127071061 | 12707106 | 5 | 2010 | 0 | ||
| 127071061 | 12707106 | 6 | 2011 | 0 | ||
| 127071061 | 12707106 | 7 | 20140528 | 0 | ||
| 127071061 | 12707106 | 8 | 20150103 | 0 | ||
| 127071061 | 12707106 | 9 | 20150103 | 0 | ||
| 127071061 | 12707106 | 10 | 20150101 | 0 | ||
| 127071061 | 12707106 | 11 | 20150601 | 0 | ||
| 127071061 | 12707106 | 12 | 2005 | 0 | ||
| 127071061 | 12707106 | 13 | 2005 | 0 | ||
| 127071061 | 12707106 | 14 | 2005 | 0 | ||
| 127071061 | 12707106 | 15 | 2011 | 0 | ||
| 127071061 | 12707106 | 16 | 2005 | 0 | ||
| 127071061 | 12707106 | 17 | 201306 | 0 | ||
| 127071061 | 12707106 | 18 | 2010 | 0 | ||
| 127071061 | 12707106 | 19 | 2005 | 0 |